Selected research
Industry Growth & Trends
Global Cannabinoid-based Antitumor Drug Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cannabinoid-based Antitumor Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cannabinoid-based Antitumor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cannabinoid-based Antitumor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cannabinoid-based Antitumor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cannabinoid-based Antitumor Drug market include Cannabics Inc., GW Pharmaceuticals, Jay Pharma, Medicanja Ltd, Tikun Olam and Valeant Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cannabinoid-based Antitumor Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cannabinoid-based Antitumor Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cannabinoid-based Antitumor Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cannabinoid-based Antitumor Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cannabinoid-based Antitumor Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cannabinoid-based Antitumor Drug Market by Company
Cannabics Inc.
GW Pharmaceuticals
Jay Pharma
Medicanja Ltd
Tikun Olam
Valeant Pharmaceuticals
Cannabinoid-based Antitumor Drug Segment by Type
Chewing Medicine
Lozenge
Other
Cannabinoid-based Antitumor Drug Segment by Application
Clinics
Hospitals
Others
Cannabinoid-based Antitumor Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabinoid-based Antitumor Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cannabinoid-based Antitumor Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabinoid-based Antitumor Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cannabinoid-based Antitumor Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Chewing Medicine
- Lozenge
- Other
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Cannabics Inc.
- GW Pharmaceuticals
- Jay Pharma
- Medicanja Ltd
- Tikun Olam
- Valeant Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cannabinoid-based Antitumor Drug Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cannabinoid-based Antitumor Drug Market Size by Region (2021-2032)
- 1.4.1 Global Cannabinoid-based Antitumor Drug Market Size by Region (2021-2026)
- 1.4.2 Global Cannabinoid-based Antitumor Drug Market Size by Region (2027-2032)
- 1.5 Key Regions Cannabinoid-based Antitumor Drug Market Size (2021-2032)
- 1.5.1 North America Cannabinoid-based Antitumor Drug Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cannabinoid-based Antitumor Drug Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cannabinoid-based Antitumor Drug Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Growth Rate (2021-2032)
2 Cannabinoid-based Antitumor Drug Market by Type
- 2.1 Type Introduction
- 2.1.1 Chewing Medicine
- 2.1.2 Lozenge
- 2.1.3 Other
- 2.2 Global Cannabinoid-based Antitumor Drug Market Size by Type
- 2.2.1 Global Cannabinoid-based Antitumor Drug Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cannabinoid-based Antitumor Drug Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cannabinoid-based Antitumor Drug Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cannabinoid-based Antitumor Drug Market Size by Regions
- 2.3.1 North America Cannabinoid-based Antitumor Drug Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cannabinoid-based Antitumor Drug Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cannabinoid-based Antitumor Drug Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cannabinoid-based Antitumor Drug Market Size Breakdown by Type (2021-2026)
3 Cannabinoid-based Antitumor Drug Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinics
- 3.1.2 Hospitals
- 3.1.3 Others
- 3.2 Global Cannabinoid-based Antitumor Drug Market Size by Application
- 3.2.1 Global Cannabinoid-based Antitumor Drug Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cannabinoid-based Antitumor Drug Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cannabinoid-based Antitumor Drug Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cannabinoid-based Antitumor Drug Market Size by Regions
- 3.3.1 North America Cannabinoid-based Antitumor Drug Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cannabinoid-based Antitumor Drug Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cannabinoid-based Antitumor Drug Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cannabinoid-based Antitumor Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cannabinoid-based Antitumor Drug Industry Trends
- 4.2 Cannabinoid-based Antitumor Drug Industry Drivers
- 4.3 Cannabinoid-based Antitumor Drug Industry Opportunities and Challenges
- 4.4 Cannabinoid-based Antitumor Drug Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cannabinoid-based Antitumor Drug Revenue (2021-2026)
- 5.2 Global Cannabinoid-based Antitumor Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cannabinoid-based Antitumor Drug Key Company Headquarters & Area Served
- 5.4 Global Cannabinoid-based Antitumor Drug Company, Product Type & Application
- 5.5 Global Cannabinoid-based Antitumor Drug Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cannabinoid-based Antitumor Drug Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cannabinoid-based Antitumor Drug Players Market Share by Revenue in 2025
- 5.6.3 2025 Cannabinoid-based Antitumor Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cannabics Inc.
- 6.1.1 Cannabics Inc. Company Information
- 6.1.2 Cannabics Inc. Business Overview
- 6.1.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cannabics Inc. Cannabinoid-based Antitumor Drug Product Portfolio
- 6.1.5 Cannabics Inc. Recent Developments
- 6.2 GW Pharmaceuticals
- 6.2.1 GW Pharmaceuticals Company Information
- 6.2.2 GW Pharmaceuticals Business Overview
- 6.2.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Product Portfolio
- 6.2.5 GW Pharmaceuticals Recent Developments
- 6.3 Jay Pharma
- 6.3.1 Jay Pharma Company Information
- 6.3.2 Jay Pharma Business Overview
- 6.3.3 Jay Pharma Cannabinoid-based Antitumor Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Jay Pharma Cannabinoid-based Antitumor Drug Product Portfolio
- 6.3.5 Jay Pharma Recent Developments
- 6.4 Medicanja Ltd
- 6.4.1 Medicanja Ltd Company Information
- 6.4.2 Medicanja Ltd Business Overview
- 6.4.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Medicanja Ltd Cannabinoid-based Antitumor Drug Product Portfolio
- 6.4.5 Medicanja Ltd Recent Developments
- 6.5 Tikun Olam
- 6.5.1 Tikun Olam Company Information
- 6.5.2 Tikun Olam Business Overview
- 6.5.3 Tikun Olam Cannabinoid-based Antitumor Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Tikun Olam Cannabinoid-based Antitumor Drug Product Portfolio
- 6.5.5 Tikun Olam Recent Developments
- 6.6 Valeant Pharmaceuticals
- 6.6.1 Valeant Pharmaceuticals Company Information
- 6.6.2 Valeant Pharmaceuticals Business Overview
- 6.6.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Product Portfolio
- 6.6.5 Valeant Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
- 7.3 North America Cannabinoid-based Antitumor Drug Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
- 8.3 Europe Cannabinoid-based Antitumor Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
- 10.3 South America Cannabinoid-based Antitumor Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst